IN | Aksjer | 579,37 M | 36 607 | IN Invesco | 0,40 | Helsevesen | NASDAQ / Biotechnology | 6.11.2014 | 72,87 | 4,94 | 21,49 |
SP | Aksjer | 571,42 M | 11 214 | SP SPDR | 0,15 | Helsevesen | S&P Health Care Select Sector Daily Capped 25/20 Index | 7.7.2015 | 49,91 | 4,86 | 22,63 |
IN | Aksjer | 555,09 M | 38 598 | IN Invesco | 0,58 | Helsevesen | Dynamic Pharmaceutical Intellidex Index (AMEX) | 23.6.2005 | 125,02 | 3,12 | 18,42 |
FU | Aksjer | 532,22 M | — | FU Fullgoal | 0,60 | Helsevesen | CSI Pharmaceutical 50 Index - CNY - Benchmark TR Gross | 16.3.2020 | 0,94 | 0,00 | 0,00 |
GU | Aksjer | 508,01 M | — | GU Guotai | 0,60 | Helsevesen | CSI Shanghai-Hong Kong-Shenzhen Innovative Pharmaceutical Industry Index - CNY - Benchmark TR Gross | 8.9.2021 | 0,75 | 3,53 | 27,58 |
VA | Aksjer | 501,96 M | 9 011 | VA VanEck | 0,35 | Helsevesen | MVIS US Listed Biotech 25 | 20.12.2011 | 246,48 | 4,63 | 23,20 |
CH | Aksjer | 489,93 M | — | CH ChinaAMC | 0,60 | Helsevesen | CSI All-Medical Device Index - CNY - Benchmark TR Gross | 23.11.2023 | 0,83 | 2,64 | 31,04 |
SP | Aksjer | 450,42 M | 152 640 | SP SPDR | 0,35 | Helsevesen | S&P Pharmaceuticals Select Industry | 19.6.2006 | 64,34 | 3,51 | 16,73 |
| Aksjer | 444,03 M | — | MO Motilal Oswal | 1,00 | Helsevesen | BSE Healthcare Index - INR - Benchmark TR Gross | 29.7.2022 | 48,05 | 5,07 | 36,04 |
IS | Aksjer | 433,09 M | 59 002 | IS iShares | 0,18 | Helsevesen | MSCI World Health Care ESG Reduced Carbon Select 20 35 Capped Index - Benchmark TR Net | 3.11.2021 | 5,60 | 4,73 | 22,23 |
IN | Aksjer | 429,04 M | 22 969 | IN Invesco | 0,59 | Helsevesen | Dynamic Biotech & Genome Intellidex Index (AMEX) | 23.6.2005 | 98,63 | 4,40 | 17,88 |
CS | Aksjer | 416,91 M | — | CS China Southern | 0,20 | Helsevesen | CSI Innovative Pharmaceutical Industrial Index - CNY - Benchmark TR Gross | 12.3.2021 | 0,65 | 3,14 | 28,61 |
| Aksjer | 405,18 M | — | MA Maxwealth | 0,60 | Helsevesen | CSI Hong Kong Stock Connect Healthcare Index - CNY - Benchmark TR Net | 2.4.2025 | 1,39 | 0,00 | 0,00 |
EV | Aksjer | 365,06 M | 22 262 | EV Evolve | 0,45 | Helsevesen | Solactive Global Healthcare 20 CAD Hedged Index - CAD | 23.10.2017 | 18,52 | 4,23 | 21,55 |
AM | Aksjer | 354,99 M | — | AM Amundi | 0,18 | Helsevesen | S&P Developed Ex-Korea LargeMidCap Sustainability Enhanced Health Care Index - EUR - Benchmark TR Net | 20.9.2022 | 10,66 | 4,64 | 21,76 |
LG | Aksjer | 353,33 M | 5 726 | LG L&G | 0,49 | Helsevesen | ROBO Global Healthcare Technology and Innovation ETF | 2.7.2019 | 18,57 | 3,12 | 25,07 |
XT | Aksjer | 338,69 M | 3 196 | XT Xtrackers | 0,17 | Helsevesen | MSCI Europe Health Care ESG Screened 20-35 Index - EUR | 26.6.2007 | 241,44 | 4,15 | 19,55 |
SI | Aksjer | 325,69 M | 117 431 | SI Simplify | 0,51 | Helsevesen | | 7.10.2021 | 39,60 | 4,73 | 22,97 |
HA | Aksjer | 290,17 M | — | HA Harvest | 0,60 | Helsevesen | SSE Science and Technology Innovation Board Biomedical Index Yield - CNY - Benchmark TR Net | 27.12.2023 | 1,05 | 0,00 | 0,00 |
IN | Aksjer | 285,48 M | 53 631 | IN Invesco | 0,74 | Helsevesen | Dorsey Wright Healthcare Tech Leaders TR | 12.10.2006 | 58,50 | 5,92 | 26,92 |
| Aksjer | 285,17 M | — | CA Capital | 1,01 | Helsevesen | NASDAQ / Biotechnology | 9.1.2017 | 36,06 | 4,93 | 21,18 |
IS | Aksjer | 283,58 M | 105 234 | IS iShares | 0,25 | Helsevesen | Dow Jones U.S. Select Medical Equipment Capped 35/20 Index | 3.8.2020 | 5,88 | 3,74 | 29,19 |
HA | Aksjer | 273,74 M | 70 817 | HA Harvest | 0,40 | Helsevesen | | 21.8.2024 | 10,75 | 0,00 | 0,00 |
HA | Aksjer | 251,5 M | 39 706 | HA Hamilton | 0,65 | Helsevesen | | 6.2.2024 | 14,73 | 4,53 | 21,67 |
HF | Aksjer | 230,12 M | — | HF Harvest Funds | 0,60 | Helsevesen | CSI Vaccine and Biotechnology Index - CNY - Benchmark TR Gross | 16.2.2023 | 0,69 | 2,19 | 38,23 |
SP | Aksjer | 223,72 M | 31 571 | SP SPDR | 0,35 | Helsevesen | S&P Health Care Services Select Industry | 28.9.2011 | 142,50 | 2,54 | 15,55 |
YI | Alternativer | 212,96 M | 319 212 | YI YieldMax | 1,00 | Helsevesen | | 23.10.2023 | 38,51 | 0,00 | 0,00 |
TE | Aksjer | 211,86 M | 31 735 | TE Tema | 0,99 | Helsevesen | | 14.8.2023 | 41,46 | 6,58 | 19,80 |
PA | Aksjer | 208,11 M | — | PA Ping An | 0,60 | Helsevesen | CSI Hong Kong Connect Healthcare - CNY - Benchmark TR Gross | 16.12.2021 | 0,92 | 2,48 | 20,11 |
HA | Aksjer | 203,39 M | — | HA Harvest | 0,60 | Helsevesen | CSI Medicine and Health 100 Strategy Index - CNY - Benchmark TR Gross | 24.4.2020 | 0,82 | 2,79 | 22,89 |
HA | Aksjer | 203,27 M | — | HA Harvest | 0,60 | Helsevesen | Hang Seng Healthcare Index - CNY - Benchmark TR Gross | 7.5.2024 | 1,55 | 2,67 | 20,30 |
| Aksjer | 195,93 M | — | SY Sygnia | 0,53 | Helsevesen | | 6.8.2021 | 29,49 | 4,30 | 21,13 |
BM | Aksjer | 191,8 M | 1 487 | BM BMO | 0,39 | Helsevesen | Solactive Equal Weight U.S. Health Care Hedged to Canada Index - CAD | 19.5.2010 | 80,93 | 3,67 | 20,81 |
DI | Aksjer | 190,65 M | 65 824 | DI Direxion | 0,94 | Helsevesen | S&P Health Care Select Sector | 15.6.2011 | 158,87 | 4,83 | 22,47 |
CH | Aksjer | 190,36 M | — | CH ChinaAMC | 0,60 | Helsevesen | CSI Hong Kong Stock Connect Healthcare Index - CNY - Benchmark TR Net | 28.7.2025 | 0,89 | 0,00 | 0,00 |
BE | Aksjer | 185,82 M | 136 838 | BE BetaShares | 0,57 | Helsevesen | Nasdaq Global ex-Australia Healthcare Hedged AUD Index - AUD | 4.8.2016 | 9,50 | 4,60 | 21,62 |
AF | Aksjer | 184 M | 42 940 | AF ALPS Funds | 0,50 | Helsevesen | S-Network Medical Breakthroughs Index | 30.12.2014 | 53,33 | 4,17 | 0,00 |
GU | Aksjer | 180,39 M | — | GU Guotai | 0,00 | Helsevesen | Hang Seng Biotechnology Index - CNY - Benchmark TR Gross | 21.1.2026 | 1,00 | 0,00 | 0,00 |
IN | Aksjer | 173,83 M | 27 120 | IN Invesco | 0,29 | Helsevesen | S&P SmallCap 600 Capped Health Care Index - Benchmark TR Gross | 7.4.2010 | 53,98 | 2,51 | 19,03 |
| Aksjer | 173,45 M | — | HW Hwabao | 0,60 | Helsevesen | CSI Hong Kong Connect Healthcare - CNY - Benchmark TR Gross | — | 0,93 | 0,00 | 0,00 |
BO | Aksjer | 168,87 M | — | BO Bosera | 0,60 | Helsevesen | CSI Pharmaceutical 50 Index - CNY - Benchmark TR Gross | 22.7.2021 | 0,58 | 3,89 | 25,29 |
EF | Aksjer | 165,58 M | — | EF E Fund | 0,00 | Helsevesen | Hang Seng Biotech Index - CNY - Benchmark TR Gross | 20.10.2025 | 0,97 | 0,00 | 0,00 |
CH | Aksjer | 157,24 M | — | CH ChinaAMC | 0,60 | Helsevesen | | 4.3.2021 | 0,62 | 2,79 | 29,27 |
GU | Aksjer | 155,73 M | — | GU Guotai | 0,60 | Helsevesen | China Securities Vaccine and Biotechnology Index - Benchmark TR Gross | 10.8.2022 | 0,58 | 0,00 | 0,00 |
IC | Aksjer | 155,32 M | — | IC ICBC | 0,52 | Helsevesen | CSI Innovative Drug Industry Index - CNY - Benchmark TR Gross | 9.2.2021 | 0,57 | 3,14 | 28,61 |
SP | Aksjer | 151,73 M | 29 865 | SP SPDR | 0,35 | Helsevesen | S&P Healthcare Equipment Select Industry | 26.1.2011 | 93,37 | 2,50 | 21,37 |
MI | Aksjer | 146,22 M | — | MI Middlefield | 1,36 | Helsevesen | | 12.2.2019 | 11,40 | 4,83 | 24,11 |
TD | Aksjer | 143,5 M | 8 330 | TD TD | 0,39 | Helsevesen | Solactive Global Healthcare Leaders Index - CAD - Benchmark TR Net | 7.4.2021 | 21,74 | 3,51 | 20,54 |
EF | Aksjer | 132,35 M | — | EF E Fund | 0,60 | Helsevesen | CSI Hong Kong Stock Connect Healthcare Index - CNY - Benchmark TR Net | 31.12.2025 | 0,86 | 0,00 | 0,00 |
IS | Aksjer | 130,28 M | 12 316 | IS iShares | 0,18 | Helsevesen | S&P 500 CAPPED 35/20 HEALTH CARE NTR | 15.6.2020 | 8,10 | 0,00 | 0,00 |
VI | etf_assetclass_Sector Equity | 129,86 M | 11 694 | VI Virtus | 0,34 | Helsevesen | LifeSci Biotechnology Products Index | 16.12.2014 | 103,89 | 5,54 | 0,00 |
| etf_assetclass_Sector Equity | 126,59 M | 4 795 | CI CIGlobal | 0,72 | Helsevesen | | 7.6.2018 | 11,89 | 3,88 | 17,87 |
AM | Aksjer | 125,69 M | — | AM Amundi | 0,18 | Helsevesen | S&P Developed Ex-Korea LargeMidCap Sustainability Enhanced Health Care Index - EUR - Benchmark TR Net | 20.9.2022 | 10,22 | 2,89 | 19,72 |
| Aksjer | 125,35 M | — | SO SOL | 0,45 | Helsevesen | FnGuide Medical Device Director Index - KRW - Benchmark Price Return | 22.8.2023 | 9 285,07 | 2,31 | 17,09 |
| Aksjer | 122 M | 4 201 | EM Emerald | 0,79 | Helsevesen | | 30.10.2024 | 42,59 | 6,27 | 0,00 |
HA | Aksjer | 118,36 M | 64 190 | HA Harvest | 0,01 | Helsevesen | | 25.10.2022 | 9,05 | 0,00 | 0,00 |
FU | Aksjer | 116,43 M | — | FU Fullgoal | 0,60 | Helsevesen | Hang Seng Biotech Index - CNY - Benchmark TR Gross | 24.12.2025 | 1,00 | 0,00 | 0,00 |
IN | Aksjer | 115,07 M | 35 112 | IN Invesco | 0,19 | Helsevesen | NASDAQ / Biotechnology | 11.6.2021 | 34,55 | 4,91 | 21,12 |
CS | Aksjer | 114,35 M | — | CS China Southern | 0,60 | Helsevesen | CSI Full Index of Medical and Healthcare Equipment and Service Index - CNY - Benchmark TR Gross | 22.10.2021 | 0,56 | 2,73 | 32,82 |
RG | Aksjer | 110,71 M | 44 077 | RG ROBO Global | 0,80 | Helsevesen | ROBO Global Healthcare Technology and Innovation ETF | 25.6.2019 | 44,28 | 3,10 | 25,46 |
KR | Aksjer | 109,58 M | 80 938 | KR KraneShares | 0,79 | Helsevesen | MSCI China All Shares Health Care 10/40 Index | 31.1.2018 | 17,82 | 3,41 | 26,60 |
PR | Aksjer | 104,94 M | 14 340 | PR ProShares | 1,08 | Helsevesen | S&P Health Care Select Sector | 30.1.2007 | 66,00 | 0,00 | 0,00 |
HE | Aksjer | 104,2 M | — | HE Harvest ETFs | 1,06 | Helsevesen | | 17.1.2017 | 7,83 | 0,00 | 0,00 |
| Aksjer | 100,55 M | — | SA Satrix | 0,48 | Helsevesen | STOXX Global Breakthrough Healthcare (USD)(NR) | 26.5.2022 | 73,03 | 0,00 | 0,00 |
PR | Aksjer | 94,85 M | 11 177 | PR ProShares | 1,17 | Helsevesen | NASDAQ / Biotechnology | 7.4.2010 | 110,29 | 0,00 | 0,00 |
DE | etf_assetclass_Leveraged/Inverse | 90,49 M | 331 908 | DE Defiance | 1,49 | Helsevesen | | 7.8.2024 | 30,62 | 0,00 | 0,00 |
MI | Aksjer | 84,3 M | 1 274 | MI Middlefield | 0,85 | Helsevesen | | 21.7.2017 | 10,44 | 0,00 | 0,00 |
CI | Aksjer | 82,21 M | — | CI CI | 0,56 | Helsevesen | Solactive Developed Markets Healthcare 150 CAD Index - CAD - Benchmark TR Net | 17.8.2021 | 23,70 | 0,00 | 0,00 |
CA | Aksjer | 78,35 M | — | CA Cathay | 0,00 | Helsevesen | ChiNext Medical and Healthcare Index - CNY - Benchmark TR Net | 2.4.2025 | 1,07 | 0,00 | 0,00 |
| Aksjer | 78,23 M | — | KS KSM | 0,73 | Helsevesen | S&P Health Care Select Sector | 4.12.2018 | 48,79 | 0,00 | 0,00 |
IS | Aksjer | 77,55 M | 36 818 | IS iShares | 0,35 | Helsevesen | NASDAQ / Biotechnology | 5.3.2018 | 10,12 | 4,93 | 21,38 |
DI | etf_assetclass_Leveraged/Inverse | 77,11 M | 18,08 M | DI Direxion | 1,08 | Helsevesen | S&P Biotechnology Select Industry | 28.5.2015 | 7,63 | 0,00 | 0,00 |
BF | Aksjer | 72,15 M | 3 372 | BF Brompton Funds | 0,75 | Helsevesen | | 24.9.2015 | 7,83 | 6,13 | 23,54 |
| Aksjer | 70,71 M | 729 191 | LE LeverageShares | 0,75 | Helsevesen | | 22.7.2025 | 22,59 | 0,00 | 0,00 |
CH | Aksjer | 62,41 M | — | CH ChinaAMC | 0,00 | Helsevesen | Shanghai Stock Exchange Science and Technology Innovation Board Biopharmaceutical Index - CNY - Benchmark TR Gross | 14.5.2025 | 1,08 | 0,00 | 0,00 |
DE | Aksjer | 60,8 M | 367 420 | DE Defiance | 1,33 | Helsevesen | | 12.3.2025 | 25,23 | 0,00 | 0,00 |
DE | etf_assetclass_Leveraged/Inverse | 60,77 M | 257 356 | DE Defiance | 1,34 | Helsevesen | | 3.2.2026 | 138,12 | 0,00 | 0,00 |
TE | Aksjer | 55,93 M | 4 028 | TE Tema | 0,99 | Helsevesen | | 20.11.2023 | 37,79 | 6,56 | 21,55 |
RI | Aksjer | 55,32 M | 18 646 | RI Roundhill Investments | 0,59 | Helsevesen | | 21.5.2024 | 29,58 | 4,01 | 14,05 |
FI | Aksjer | 52,31 M | 7 787 | FI Fidelity | 0,50 | Helsevesen | | 16.4.2020 | 31,59 | 4,23 | 37,59 |
VA | Aksjer | 50,79 M | — | VA VanEck | 0,45 | Helsevesen | MarketGrader Developed Markets ex-Australia Health Care Index - AUD | 8.9.2020 | 11,35 | 4,95 | 21,34 |
GX | Aksjer | 47,37 M | 2 301 | GX Global X | 0,45 | Helsevesen | S&P Biotechnology Select Industry | 8.11.2018 | 73,55 | 5,08 | 0,00 |
MI | Aksjer | 45,87 M | 33 | MI Middlefield | 0,27 | Helsevesen | | 20.10.2016 | 12,33 | 4,47 | 21,53 |
AD | Aksjer | 44,57 M | 38 780 | AD AdvisorShares | 1,84 | Helsevesen | | 15.9.2021 | 20,68 | 3,48 | 0,00 |
HA | Aksjer | 43,58 M | 4 339 | HA Harbor | 0,80 | Helsevesen | | 16.11.2022 | 33,53 | 11,65 | 33,30 |
FU | Aksjer | 40,7 M | — | FU Fullgoal | 0,60 | Helsevesen | CSI Vaccine and Biotechnology Index - CNY - Benchmark TR Gross | 16.9.2022 | 0,66 | 2,00 | 29,03 |
VI | etf_assetclass_Sector Equity | 40 M | 24 907 | VI Virtus | 0,65 | Helsevesen | LifeSci Biotechnology Clinical Trials Index | 16.12.2014 | 42,10 | 4,22 | 0,00 |
IS | Aksjer | 38,78 M | 7 141 | IS iShares | 0,18 | Helsevesen | | 21.3.2018 | 41,39 | 4,27 | 23,49 |
DE | Aksjer | 38,71 M | 423 831 | DE Defiance | 1,31 | Helsevesen | | 2.12.2024 | 10,06 | 0,00 | 0,00 |
IS | Aksjer | 36,79 M | 3 797 | IS iShares | 0,18 | Helsevesen | | 21.3.2018 | 34,13 | 5,85 | 16,28 |
PU | Aksjer | 36,24 M | — | PU Purpose | 0,00 | Helsevesen | | 7.2.2025 | 7,98 | 0,00 | 0,00 |
| Aksjer | 34,05 M | 7 364 | TR T. Rowe | 0,44 | Helsevesen | | 11.6.2025 | 34,05 | 3,97 | 25,60 |
SP | Aksjer | 32,92 M | 40 911 | SP SPDR | 0,35 | Helsevesen | S&P Health Care Select Sector | 29.7.2025 | 27,21 | 0,00 | 0,00 |
EV | Aksjer | 32,67 M | — | EV Evolve | 0,72 | Helsevesen | Solactive Global Healthcare 20 Index - CAD | 25.10.2017 | 22,60 | 0,00 | 0,00 |
GX | Aksjer | 32,28 M | 9 235 | GX Global X | 0,50 | Helsevesen | Global X HealthTech Index - Benchmark TR Net | 29.7.2020 | 30,74 | 3,67 | 26,47 |
| Aksjer | 31,72 M | — | TA Tachlit | 1,23 | Helsevesen | NASDAQ / Biotechnology | 13.11.2018 | 152,42 | 0,00 | 0,00 |
TR | Aksjer | 31,51 M | 254 182 | TR Tradr | 1,30 | Helsevesen | | 12.5.2025 | 25,05 | 0,00 | 0,00 |
SM | etf_assetclass_Sector Equity | 31,13 M | 12 610 | SM Smartshares | 0,75 | Helsevesen | STOXX Global Breakthrough Healthcare (USD)(NR) | 6.6.2019 | 4,34 | 0,00 | 0,00 |
HE | Aksjer | 30,63 M | — | HE Harvest ETFs | 0,00 | Helsevesen | | 21.8.2024 | 9,22 | 0,00 | 0,00 |
LG | Aksjer | 29,17 M | 1 650 | LG L&G | 0,49 | Helsevesen | Solactive Pharma Breakthrough Value Index | 23.1.2018 | 14,80 | 3,62 | 18,36 |